MOLE', Daniela
 Distribuzione geografica
Continente #
NA - Nord America 3.220
AS - Asia 1.620
EU - Europa 1.187
SA - Sud America 280
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 2
Totale 6.383
Nazione #
US - Stati Uniti d'America 3.160
SG - Singapore 595
CN - Cina 435
FR - Francia 214
BR - Brasile 211
DE - Germania 193
VN - Vietnam 189
UA - Ucraina 166
PL - Polonia 143
IT - Italia 127
HK - Hong Kong 126
GB - Regno Unito 97
TR - Turchia 97
FI - Finlandia 94
SE - Svezia 53
JP - Giappone 45
RU - Federazione Russa 43
BD - Bangladesh 33
IN - India 31
CA - Canada 30
AR - Argentina 23
MX - Messico 18
ZA - Sudafrica 17
IQ - Iraq 13
EC - Ecuador 12
NL - Olanda 12
ID - Indonesia 11
ES - Italia 9
VE - Venezuela 9
CO - Colombia 8
LT - Lituania 8
UZ - Uzbekistan 8
CL - Cile 7
PK - Pakistan 7
AT - Austria 6
BE - Belgio 6
KE - Kenya 6
TN - Tunisia 5
IE - Irlanda 4
JM - Giamaica 4
JO - Giordania 4
PY - Paraguay 4
CH - Svizzera 3
DZ - Algeria 3
EU - Europa 3
LB - Libano 3
NP - Nepal 3
PH - Filippine 3
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
MA - Marocco 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
ML - Mali 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 6.353
Città #
Ashburn 405
Singapore 401
Woodbridge 268
San Jose 207
Chandler 205
Fairfield 199
Jacksonville 186
Houston 169
Santa Clara 146
Warsaw 143
Beijing 138
Ann Arbor 132
Hong Kong 123
Wilmington 85
Seattle 77
Cambridge 65
Ho Chi Minh City 63
Los Angeles 57
Munich 56
Council Bluffs 54
Addison 52
Tokyo 45
Hanoi 44
Nanjing 44
Izmir 42
New York 42
Helsinki 35
Princeton 35
Boardman 32
Lauterbourg 31
Dallas 30
Shanghai 26
Turku 26
Dearborn 25
Ferrara 25
Milan 24
São Paulo 24
Buffalo 21
Bremen 20
San Diego 17
Shenyang 17
Jinan 15
Nuremberg 15
Brooklyn 14
Atlanta 13
Denver 13
Frankfurt am Main 13
Johannesburg 13
Mountain View 13
Nanchang 12
Chennai 11
Da Nang 11
London 11
Orem 11
Tianjin 11
Washington 11
Chicago 10
Manchester 10
Mexico City 10
Rome 10
Haiphong 9
Montreal 9
Hebei 8
Jiaxing 8
L’Aquila 8
Newark 8
Poplar 8
Auburn Hills 7
Changsha 7
Moscow 7
Phoenix 7
Tashkent 7
Brussels 6
Guayaquil 6
Jakarta 6
Norwalk 6
Orange 6
Rio de Janeiro 6
Stockholm 6
Amsterdam 5
Baghdad 5
Boston 5
Brasília 5
Caracas 5
Dhaka 5
Guangzhou 5
Hefei 5
Hải Dương 5
Indiana 5
Nairobi 5
New Delhi 5
Amman 4
Ankara 4
Augusta 4
Cagliari 4
Catalão 4
Charlotte 4
Curitiba 4
Dublin 4
Medellín 4
Totale 4.294
Nome #
PKC COME NUOVO TARGET MOLECOLARE NEL CONTROLLO DELLA PROLIFERAZIONE CELLULARE DEI TUMORI NEUROENDOCRINI 420
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 257
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 236
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 226
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 221
Growth hormone excess promotes breast cancer chemoresistance 217
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 215
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 212
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 205
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 204
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 198
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 191
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 191
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 191
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 188
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 187
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 185
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 183
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 183
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 180
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 180
ctivation of EGFR promotes ACC cell proliferation by inducing VEGF autocrine secretion 172
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 169
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 165
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 161
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 157
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 148
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 148
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 144
Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line 131
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 124
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 123
Targeting PKC in human pancreatic neuroendocrine tumor cells 121
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  110
null 40
Totale 6.383
Categoria #
all - tutte 26.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.415


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022300 0 28 15 3 13 18 10 8 8 34 43 120
2022/2023422 39 39 20 55 77 52 19 36 57 0 15 13
2023/2024252 21 22 11 9 16 41 9 77 3 3 2 38
2024/2025863 22 19 58 18 122 125 25 18 100 95 124 137
2025/20262.380 205 104 173 282 452 249 292 97 212 212 80 22
2026/2027126 51 75 0 0 0 0 0 0 0 0 0 0
Totale 6.383